101 results
Page 3 of 6
8-K
gymo1e61jt
2 Jul 20
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-1.1
xvu7oj229r8dpv3
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.2
odvde5 ng8xtvkq6f6
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
424B5
ltgo939lmvz96x ea6h
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
xb5vlxk
19 May 20
Prospectus supplement for primary offering
5:08pm
FWP
4caljm
19 May 20
Free writing prospectus
6:06am
424B5
l90nx
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
dehrrnwnq p2uu4478o
18 May 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
qbg1h5 qltwcbyze
12 May 20
Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
4:18pm
DEFA14A
3310m77j
27 Apr 20
Additional proxy soliciting materials
4:20pm
S-3ASR
2netwucbvfg41 mc6bg
10 Apr 20
Automatic shelf registration
4:33pm
8-K
EX-99.1
0zyj4geo
24 Mar 20
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
8:45am
8-K
EX-99.1
q4wo fbnndmltoq
12 Nov 19
Gossamer Bio Announces Third Quarter 2019 Financial Results
4:10pm